“The US Food and Drug Administration (FDA) has today granted approval to PIC for the gene edit used in its [porcine reproductive and respiratory syndrome virus (PRRS)]-resistant pig, determining that the technology is safe and effective…

The FDA-approved gene edit will be used to breed PIC’s PRRS-resistant pigs, helping to tackle one of the most devastating, global swine diseases that affects pig health and welfare, exacerbating the need for antibiotics and increases the environmental impact of raising pigs.

FDA approval does not automatically trigger commercialization in the US, however. Among the barriers to overcome will be need for countries trades pork with to accept the technology…

While the disease-resistant technology is new, pork from PRRS-resistant pigs is no different to other pork, except for resistance to the infection caused by the PRRS virus. This was confirmed by a recent study which reviewed 97 meat quality and composition data points, PIC said.”

From Pig World.